Literature DB >> 15174146

Proteomic analysis of mouse mammary terminal end buds identifies axonal growth cone proteins.

Joanna S Morris1, Claire R Davies, Matthew R Griffiths, Martin J Page, James A Bruce, Thakor Patel, Athula Herath, Barry A Gusterson.   

Abstract

Ductal morphogenesis in the mouse mammary gland occurs mainly postnatally and is driven by specialized structures at the ends of the developing ducts, the terminal end buds (TEBs), which later regress once ductal growth is complete. To identify proteins that are specifically associated with migration of TEBs we developed a novel method of isolating TEBs, which eliminated the mammary stroma. The protein expression profile of the TEBs was then compared with that of isolates taken from the 4th inguinal mammary gland of adult virgin mice using two-dimensional (2-D) gel electrophoresis and mass spectrometry (MS) analysis (matrix-assisted laser desorption/ionization and quadrupole time of flight). Following construction of an integrated protein expression database, 44 protein features which showed differential expression levels between the two sets were chosen for MS analysis. Of these, 24 gave protein annotations whereas the other 20 produced unidentified peptides. Fourteen unequivocal proteins were identified from these 24, whereas the remaining 10 matched more than one protein within a single 2-D gel feature. Several of the identified proteins were associated with the cytoskeleton and have previously been reported in axonal growth cones, suggesting that they may influence cell shape and motility within the advancing TEBs, in a similar fashion to migrating axons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174146     DOI: 10.1002/pmic.200300699

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  4 in total

1.  Clinical significance of SPRR1A expression in progesterone receptor-positive breast cancer.

Authors:  Guanglei Chen; Gang Li; Minna Luo; Xiaofei Wei; Dan Wang; Hao Zhang; Xinhan Zhao; Bo Chen; Caigang Liu
Journal:  Tumour Biol       Date:  2014-11-26

2.  Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.

Authors:  Isabelle Mercier; Mathew C Casimiro; Jie Zhou; Chenguang Wang; Christopher Plymire; Kelly G Bryant; Kristin M Daumer; Federica Sotgia; Gloria Bonuccelli; Agnieszka K Witkiewicz; Justin Lin; Thai Hong Tran; Janet Milliman; Philippe G Frank; Jean-François Jasmin; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

3.  Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor.

Authors:  Kazuhide Watanabe; Alvaro Villarreal-Ponce; Peng Sun; Michael L Salmans; Magid Fallahi; Bogi Andersen; Xing Dai
Journal:  Dev Cell       Date:  2014-04-14       Impact factor: 12.270

4.  SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24+ CD49fhi Mammary Stem Cell-Enriched Compartment.

Authors:  Genevieve V Dall; Jessica L Vieusseux; Kenneth S Korach; Yukitomo Arao; Sylvia C Hewitt; Katherine J Hamilton; Elaine Dzierzak; Wah Chin Boon; Evan R Simpson; Robert G Ramsay; Torsten Stein; Joanne S Morris; Robin L Anderson; Gail P Risbridger; Kara L Britt
Journal:  Stem Cell Reports       Date:  2017-01-26       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.